Literature DB >> 10559077

A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise.

S Grant1, T Aitchison, E Henderson, J Christie, S Zare, J McMurray, H Dargie.   

Abstract

OBJECTIVE: To assess which subjective scale, the visual analogue scale (VAS), the Borg CR10 (Borg) scale, or the Likert scale (LS), if any, is decidedly more reproducible and sensitive to change in the assessment of symptoms.
DESIGN: Prospective clinical study.
SETTING: Exercise laboratory. PARTICIPANTS: Twenty-three physically active male subjects (mean +/- SD age of 30 +/- 4 years old) were recruited. INTERVENTION: Each subject attended the exercise laboratory on four occasions at intervals of 1 week. Three subjective scales were used: (1) the VAS (continuous scale); (2) the Borg scale (12 fixed points); and (3) the Likert scale (LS; 5 fixed points). Four identical submaximal tests were given (2 min at 60% maximum oxygen uptake [VO(2)max] and 6 min at 70% VO(2)max). Two tests were undertaken to assess the reproducibility of scores that were obtained with each subjective scale. Two other tests were undertaken to assess the sensitivity of each scale to a change in symptom perception: a double-blind treatment with propranolol, 80 mg, (ie, active therapy; to increase the sensation of breathlessness and general fatigue during exercise) or matching placebo. The subjective scale scores were measured at 1 min 30 s, 5 min 30 s, and 7 min 15 s of exercise. Reproducibility was defined as the proportion of total variance (ie, between-subject plus within-subject variance) explained by the between-subject variance given as a percentage. Sensitivity was defined as the effect of the active drug therapy over the variation within subjects.
RESULTS: Overall, the VAS performed best in terms of reproducibility for breathlessness and general fatigue, with reproducibility coefficients as high as 78%. For sensitivity, the VAS was best for breathlessness (ratio, 2.7) and the Borg scale was most sensitive for general fatigue (ratio, 3.0). The relationships between the respective psychological and physiologic variables were reasonably stable throughout the testing procedure, with overall typical correlations of 0.73 to 0.82
CONCLUSION: This study suggests that subjective scales can reproducibly measure symptoms during steady-state exercise and can detect the effect of a drug intervention. The VAS and Borg scales appear to be the best subjective scales for this purpose.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559077     DOI: 10.1378/chest.116.5.1208

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  104 in total

1.  Comparison between the CR10 Borg's scale and the VAS (visual analogue scale) during an arm-cranking exercise.

Authors:  E M Capodaglio
Journal:  J Occup Rehabil       Date:  2001-06

2.  Auricular acupuncture, education, and smoking cessation: a randomized, sham-controlled trial.

Authors:  Ian D Bier; Jeffrey Wilson; Pat Studt; Mary Shakleton
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

3.  Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.

Authors:  Letizia Leocani; Arturo Nuara; Elise Houdayer; Irene Schiavetti; Ubaldo Del Carro; Stefano Amadio; Laura Straffi; Paolo Rossi; Vittorio Martinelli; Carlos Vila; Maria Pia Sormani; Giancarlo Comi
Journal:  J Neurol       Date:  2015-08-20       Impact factor: 4.849

4.  Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults.

Authors:  Samer S El-Kamary; Melissa Billington; Stephen Deitz; Elaina Colby; Howard Rhinehart; Yukun Wu; William Blackwelder; Robert Edelman; Albert Lee; Alan King
Journal:  Mol Ther       Date:  2011-11-08       Impact factor: 11.454

5.  Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; J J Gestal-Otero
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Development of a provisional core set of response measures for clinical trials of systemic sclerosis.

Authors:  D Khanna; D J Lovell; E Giannini; P J Clements; P A Merkel; J R Seibold; M Matucci-Cerinic; C P Denton; M D Mayes; V D Steen; J Varga; D E Furst
Journal:  Ann Rheum Dis       Date:  2007-09-24       Impact factor: 19.103

8.  Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.

Authors:  Malissa C Diehl; Jessica C Lee; Stephen E Daniels; Pablo Tebas; Amir S Khan; Mary Giffear; Niranjan Y Sardesai; Mark L Bagarazzi
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

9.  What keeps a body moving? The brain-derived neurotrophic factor val66met polymorphism and intrinsic motivation to exercise in humans.

Authors:  Ann E Caldwell Hooper; Angela D Bryan; Martin S Hagger
Journal:  J Behav Med       Date:  2014-05-08

10.  Effectiveness of sensorimotor training in patients with rheumatoid arthritis: a randomized controlled trial.

Authors:  Kelson Nonato Gomes da Silva; Lucas Emmanuel Pedro de Paiva Teixeira; Aline Mizusaki Imoto; Alvaro Nagib Atallah; Maria Stella Peccin; Virginia Fernandes Moça Trevisani
Journal:  Rheumatol Int       Date:  2013-03-03       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.